Sample Preparation for Mass-spectrometry-based Proteomics Analysis of Ocular Microvessels
February 22nd, 2019
Proteome characterization of ocular microvascular beds is pivotal for in-depth understanding of many ocular pathologies in humans. This study demonstrates an effective, rapid, and robust method for protein extraction and sample preparation from small blood vessels employing the porcine short posterior ciliary arteries as model vessels for mass-spectrometry-based proteomics analyses.
Overview
This study focuses on the proteome characterization of ocular microvascular beds, crucial for understanding ocular diseases. Utilizing porcine short posterior ciliary arteries as a model, it presents a rapid and robust protein extraction method for mass-spectrometry-based proteomic analysis.
Key Study Components
Research Area
- Proteomics
- Ocular biology
- Molecular mechanisms in ocular pathologies
Background
- Understanding of ocular microvasculature is essential for elucidating health and disease mechanisms.
- Mass-spectrometry-compatible samples are critical for comprehensive proteome analysis.
- The workflow developed can apply to various cell and tissue-based samples.
Methods Used
- Protein extraction from porcine short posterior ciliary arteries
- Use of homogenizers and centrifugation for sample preparation
- One-dimensional gel electrophoresis for protein separation
Main Results
- Successful methodology for the isolation and preparation of ocular blood vessels.
- Production of high-quality samples suitable for mass spectrometry.
- Demonstration of the approach's versatility for other biological samples.
Conclusions
- The study establishes a reliable methodology for proteome analysis of ocular microblood vessels.
- This work contributes significantly to ocular biology research and the understanding of ocular diseases.
Frequently Asked Questions
Executive Industry Relevance
Robust sample preparation is critical for reliable proteomic analysis of mass-limited ocular microvessels, enabling mechanistic de-risking in target validation for ophthalmic drug discovery. This workflow supports predictive confidence by ensuring reproducible protein extraction from supernatant and pellet fractions, facilitating downstream biomarker identification and pathway analysis. The method’s adaptability to other tissue-based samples enhances enterprise reuse across discovery pipelines.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by isolating protein signaling pathways in ocular vascular beds.
- Operational Value: Provides standardized protein extraction from supernatant and pellet, reducing variability in target engagement studies.
- Predictive Value: Supports biomarker discovery and mechanistic de-risking through high-quality MS-compatible samples.
Screening & Assay Development
- Scientific Value: Prepares validated biological systems for assay standardization using cleaned protein extracts.
- Operational Value: Ensures reproducibility via centrifugal filter cleaning and gel electrophoresis steps.
- Scalability: Enables platform reuse across tissue types, supporting consistent compound screening readiness.
Translational & Preclinical Research
- Scientific Value: Maintains disease relevance by preserving ocular microvessel proteome integrity for translational biomarker alignment.
- Operational Value: Facilitates continuity from discovery to preclinical validation through consistent sample preparation.
- Risk Mitigation: Supports risk-adjusted advancement decisions by minimizing sample loss in mass-limited analyses.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by enabling hypothesis testing and pathway clarification in ocular vasculatures, supporting lead identification through reliable proteomic profiling.
- Discovery Biology: Supports hypothesis testing and biological de-risking via protein extraction from supernatant and pellet fractions.
- Screening: Ensures assay readiness through contaminant removal and standardized protein quantification.
- Analytics: Generates quantitative peptide outputs for label-free LC-MS/MS analysis, enabling condition comparisons.
- Translational Research: Connects discovery to preclinical continuity by preserving ocular vascular proteome integrity.
- Enterprise Reuse: Adaptable to other tissue-based samples, positioning it as a reusable capability across discovery teams.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through high-yield, reproducible protein extraction from mass-limited samples.
- Operational Value: Standardization and scalability via centrifugal filter cleaning and reproducible gel electrophoresis.
- Strategic Value: Improved go/no-go decisions by reducing false negatives in target validation assays.
- Portfolio Impact: Risk-adjusted prioritization via reliable proteomic data from ocular microvessels.
Implementation Considerations
- Expertise in microsurgical isolation of ocular microvessels and protein extraction techniques.
- Instrumentation including homogenizers, centrifuges, ultrasonic processors, and LC-MS/MS systems.
- Cross-team standardization of sample cleaning and fractionation protocols.
- Adaptation considerations for varying tissue densities and protein yields across model systems.
- Practical limitations include sample loss during multiple filtration steps and dependency on complete homogenization.
Biopharma FAQs
Chapters in this video
0:04
Title
1:02
Isolation of Short Posterior Ciliary Arteries
2:17
Sample Preparation
3:43
Pellet Digestion
4:40
Sample Cleaning and Buffer Exchange
5:40
One-dimensional Gel Electrophoresis (1DE)
6:50
In-gel Tryptic Digestion
9:23
Results: Comparison of Protein Extraction Efficacy and Robustness and Representative 1DE Gel Analysis
10:51
Conclusion
